Science, The New York Times

Articles

• Nobel Prize in Physics Awarded to Scientists Who Put Light to Work

  3 octobre, par DENNIS OVERBYE — Ashkin, Arthur, Mourou, Gerard, Strickland, Donna (1959- ), Nobel Prizes, Physics, Swedish Academy
  Arthur Ashkin, Gérard Mourou and Donna Strickland developed tools made of light beams. Dr. Strickland is just the third woman to win the physics prize.
  

• First Woman in 55 Years Wins the Nobel Prize in Physics

  3 octobre — Strickland, Donna (1959- ), Women and Girls, Nobel Prizes, Physics, Laser (Light Amplification by Stimulated Emission of Radiation)
  Prof. Donna Strickland won the Nobel Prize in Physics for her work with lasers. She is the first woman to receive the award in 55 years and the third woman to receive it in over a century.
  

• F.D.A. Seizes Documents From Juul Headquarters

  3 octobre, par JAN HOFFMAN — Food and Drug Administration, E-Cigarettes, Juul Labs Inc, Advertising and Marketing, Teenagers and Adolescence, Nicotine, Regulation and Deregulation of Industry
  The latest move by the agency to increase pressure on e-cigarette makers to curtail marketing their products to teenagers.
  

• Memorial Sloan Kettering’s Chief Executive Resigns From Merck’s Board of Directors

  3 octobre, par KATIE THOMAS and CHARLES ORNSTEIN — Thompson, Craig B, Memorial Sloan-Kettering Cancer Center, Executive Compensation, Boards of Directors, Conflicts of Interest, Merck & Company Inc, Charles River Laboratories
  Under scrutiny for the hospital’s industry ties and compensation, Dr. Craig B. Thompson stepped down from two company boards.
  

• These Cholesterol-Reducers May Save Lives. So Why Aren’t Heart Patients Getting Them?

  2 octobre, par GINA KOLATA — Repatha (Drug), Drugs (Pharmaceuticals), Health Insurance and Managed Care, Cholesterol, Prices (Fares, Fees and Rates), Heart, Amgen Inc, CIGNA Corporation, Express Scripts Inc, Regeneron Pharmaceuticals Inc
  Powerful PCSK9 inhibitors were supposed to revolutionize care for cardiac patients. But insurers and other payers balked at sky-high prices.
  

• Ivy League Football Saw Large Reduction in Concussions After New Kickoff Rules

  2 octobre, par SARAH MERVOSH — Football (College), Concussions, Ivy League, National Collegiate Athletic Assn, Journal of the American Medical Assn
  The Ivy League adjusted its kickoff and touchback lines by just five yards. The number of concussions per 1,000 kickoff plays dropped from 11 to two, a new study found.
  

• A Man Died After Being Infected With a Brain-Eating Amoeba. Here Are the Facts.

  2 octobre, par CHRISTINE HAUSER — Brain, Lakes, Naegleria Fowleri, Centers for Disease Control and Prevention, Florida, Texas, Infections, Stabile, Fabrizio
  A New Jersey man contracted the infection after visiting a surf and water park in Texas. Experts say the amoeba is found in warm bodies of fresh water.
  

• Breakthrough Leukemia Treatment Backfires in a Rare Case

  2 octobre, par DENISE GRADY — Leukemia, Immune System, Immunotherapy, Genetic Engineering, Cancer, Children's Hospital of Philadelphia, University of Pennsylvania, Novartis AG, Whitehead, Emma, Kymriah, Drugs (Pharmaceuticals), Nature Medicine (Journal), Ruella, Marco
  The groundbreaking treatment that genetically engineers a patient’s own cells to fight leukemia turned lethal in one patient, reversing his remission.
  

• Cancer Center’s Board Chairman Faults Top Doctor Over ‘Crossed Lines’

  2 octobre, par CHARLES ORNSTEIN and KATIE THOMAS — Memorial Sloan-Kettering Cancer Center, Baselga, Jose, Thompson, Craig B, Warner, Douglas A III, Hospitals, Boards of Directors, Executive Compensation, Conflicts of Interest, Drugs (Pharmaceuticals)
  The executive told Memorial Sloan Kettering’s staff that the hospital had not done enough to limit the industry conflicts of its chief medical officer, who has resigned.
  

• 2018 Nobel Prize in Medicine Awarded to 2 Cancer Immunotherapy Researchers

  2 octobre, par DENISE GRADY — Nobel Prizes, Allison, James P, Honjo, Tasuku, Immunotherapy, Cancer
  James P. Allison and Tasuku Honjo were recognized for a discovery that the body’s immune system can be used to attack cancer cells.